微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1.77% | 293.33% | 77% | 42/69 | 2.26% | 天目药业 | 9.27% | 行业排名> |
| 2024-12-31 | 1% | -93.87% | 212.5% | 48/69 | 3.28% | 天目药业 | 22.26% | 行业排名> |
| 2024-09-30 | 0.32% | -97.57% | 966.67% | 58/69 | 3.08% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-06-30 | 0.03% | -99.71% | -93.33% | 58/69 | 0.67% | 羚锐制药 | 13.25% | 行业排名> |
| 2024-03-31 | 0.45% | -93.78% | -97.24% | 57/69 | 1.53% | 片仔癀 | 7.03% | 行业排名> |
| 2023-12-31 | 16.3% | 21.19% | 23.86% | 9/69 | 0.11% | 片仔癀 | 23.1% | 行业排名> |
| 2023-09-30 | 13.16% | 65.74% | 27.27% | 11/69 | 7.26% | 太极集团 | 22.08% | 行业排名> |
| 2023-06-30 | 10.34% | 128.26% | 42.82% | 11/69 | 4.93% | 太极集团 | 17.13% | 行业排名> |
| 2023-03-31 | 7.24% | 103.94% | -46.17% | 5/69 | 3.21% | 以岭药业 | 10.43% | 行业排名> |
| 2022-12-31 | 13.45% | 30.08% | 69.4% | 14/69 | 6.65% | *ST吉药 | 72.63% | 行业排名> |
| 2022-09-30 | 7.94% | -15.98% | 75.28% | 27/69 | 5.16% | 片仔癀 | 23.54% | 行业排名> |
| 2022-06-30 | 4.53% | -19.11% | 27.61% | 29/69 | 3.2% | 片仔癀 | 19.69% | 行业排名> |
| 2022-03-31 | 3.55% | -6.08% | -65.67% | 16/69 | 2.18% | 片仔癀 | 12.75% | 行业排名> |
| 2021-12-31 | 10.34% | 234.63% | 9.42% | 26/69 | 4.54% | 片仔癀 | 6.88% | 行业排名> |
| 2021-09-30 | 9.45% | 266.28% | 68.75% | 24/69 | 7.54% | 片仔癀 | 27.39% | 行业排名> |
| 2021-06-30 | 5.6% | 233.33% | 48.15% | 25/69 | 4.68% | 片仔癀 | 23.14% | 行业排名> |
| 2021-03-31 | 3.78% | 95.85% | 22.33% | 16/69 | 2.7% | 片仔癀 | 13.23% | 行业排名> |
| 2020-12-31 | 3.09% | -78.36% | 19.77% | 50/69 | 0.1% | *ST长药 | 7.37% | 行业排名> |
| 2020-09-30 | 2.58% | -77.35% | 53.57% | 57/69 | 6.79% | 沃华医药 | 22.84% | 行业排名> |
| 2020-06-30 | 1.68% | -77.63% | -12.95% | 51/69 | 3.75% | 沃华医药 | 19.47% | 行业排名> |
| 2020-03-31 | 1.93% | -45.63% | -86.48% | 36/69 | 2.14% | 沃华医药 | 12.7% | 行业排名> |
| 2019-12-31 | 14.28% | 4.69% | 25.37% | 12/69 | 5.86% | 济川药业 | 7.33% | 行业排名> |
| 2019-09-30 | 11.39% | -1.64% | 51.66% | 11/69 | 7.3% | 济川药业 | 27.43% | 行业排名> |
| 2019-06-30 | 7.51% | 18.08% | 111.55% | 14/69 | 4.72% | 济川药业 | 23.05% | 行业排名> |
| 2019-03-31 | 3.55% | 51.06% | -73.97% | 20/69 | 2.92% | 济川药业 | 15.79% | 行业排名> |
| 2018-12-31 | 13.64% | 29.29% | 17.79% | 18/69 | 7.87% | 华润三九 | 10.23% | 行业排名> |
| 2018-09-30 | 11.58% | 31.74% | 82.08% | 12/69 | 8.02% | 济川药业 | 32.79% | 行业排名> |
| 2018-06-30 | 6.36% | 10.61% | 170.64% | 25/69 | 5.03% | 济川药业 | 27.55% | 行业排名> |
| 2018-03-31 | 2.35% | 12.44% | -77.73% | 37/69 | 2.75% | 济川药业 | 17.62% | 行业排名> |
| 2017-12-31 | 10.55% | -1.59% | 20.02% | 32/69 | 9.93% | 济川药业 | 10.07% | 行业排名> |
| 2017-09-30 | 8.79% | 10.15% | 52.87% | 29/69 | 8.39% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-06-30 | 5.75% | 10.36% | 175.12% | 27/69 | 5.24% | 济川药业 | 24.2% | 行业排名> |
| 2017-03-31 | 2.09% | -14.69% | -80.5% | 37/69 | 2.62% | *ST大药 | 15.31% | 行业排名> |
| 2016-12-31 | 10.72% | 5.51% | 34.34% | 31/69 | 10.02% | 济川药业 | 14.64% | 行业排名> |
| 2016-09-30 | 7.98% | -2.44% | 53.17% | 32/69 | 9.32% | 济川药业 | 7.64% | 行业排名> |
| 2016-06-30 | 5.21% | -2.98% | 112.65% | 32/69 | 5.04% | 维康药业 | 38.23% | 行业排名> |
| 2016-03-31 | 2.45% | -11.55% | -75.89% | 33/69 | 4.1% | 太极集团 | 58.41% | 行业排名> |
| 2015-12-31 | 10.16% | -33.38% | 24.21% | 38/69 | 11.34% | 新光药业 | 16.54% | 行业排名> |
| 2015-09-30 | 8.18% | -43.93% | 52.33% | 32/69 | 8.44% | 太极集团 | 71.6% | 行业排名> |
| 2015-06-30 | 5.37% | 2% | 93.86% | 32/69 | 5.48% | 维康药业 | 48.67% | 行业排名> |
| 2015-03-31 | 2.77% | 2% | -81.84% | 29/69 | 2.9% | 济川药业 | 21.37% | 行业排名> |